Neighborhood factors and quitting smoking in Ontario Presented by: Sarah Edwards *, Susan Bondy *, Russell Callaghan †,*, Robert Mann ‡,* * Dalla Lana.

Slides:



Advertisements
Similar presentations
Results of a smoking cessation intervention programme in the workplace: lessons learnt Dr. Timea TOTH Ruzsas E, Biro B, Olajos A, Nikl A, Jelencsics Zs.
Advertisements

Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
Fertility history and health in later life: A study among older women and men in the British Household Panel Survey Sanna Read and Emily Grundy Centre.
Results Introduction Tobacco use is the leading preventable cause of death in Wisconsin and the United States. Given the risk of smoking initiation during.
Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore Effectiveness Of Nurse-clinician Led Smoking Cessation Clinic In Singapore PRABHAKARAN.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
The Evaluation of Canada’s Health Warning Messages: 18 Month Follow-Up Murrray Kaiserman 1, Eva M. Makomaski Illing 1, Donna Dasko 2 1 Tobacco Control.
Socioeconomic Status and Smoking in Canada, : Has there been any progress on disparities in tobacco use? Jessica Reid, David Hammond, Pete Driezen.
Dejar de Fumar Hoy - Quit Smoking Now: A Smoking Cessation Program for Latinos Sally Haack, Pharm.D., BCPS; Naomi Barasch, Pharm.D. Candidate Drake University.
Smoking Cessation Ruby Poppleton Health Improvement Specialist.
Positive smoker identity as a barrier to quitting smoking: Findings from a national survey of smokers in England Ildiko Tombor, Lion Shahab, Jamie Brown,
Who tries how? Quit attempts among Swedish smokers Lars M. Ramström Institute for tobacco studies Stockholm, Sweden 6th Annual Conference of the SRNT Europe.
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Journal Club Alcohol and Health: Current Evidence May–June 2005.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
Differences in Responses to Text Health Warnings by Ethnicity: A Possible Benefit of Indigenous Language Usage? Judy Li, 1 Nick Wilson, 1 Deepa Weerasekera,
Exposure to Onscreen Tobacco in Movies among Ontario Youth Robert Schwartz Ontario Tobacco Research Unit Dalla Lana School of Public Health, University.
Session 7—Presentation and Panel Discussion International Quitline Institute 2011 Conference October 11, 2011 Seattle, Washington National Center for Chronic.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
Smoking cessation outcomes of an intensive tobacco treatment program within mental health and addictions services Chizimuzo Okoli, PhD, MPH, RN Director,
Demonstration of a Process- Outcome Link for Smoking Cessation Melissa M. Farmer, PhD 1,2 Elizabeth M. Yano, PhD 1,2 Brian S. Mittman, PhD 1,2 Scott E.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Sample Text 1 Tobacco in Mental Illness and Addictions : Prevalent and overrepresented Consuming 44% of cigarettes smoked Lethal Treatable, yet remaining.
Linking Quitline Counseling & Medication Post Hospital Discharge via iPad App Post Hospital Discharge via iPad App Canadian Cancer Society Smokers’ Helpline.
Roll-your-own smokers and quitting through the Quitline Judy Li, MSc Researcher The Quit Group.
Smoke-Free Homes & Smoking Cessation TUS-CPS overlap sample Karen Messer, Ph D Moores UCSD Cancer Center.
A focus on racial/ethnic health disparities with the TUS Dennis R. Trinidad, Ph.D., MPH TUS CPS NCTOH Pre-Conference Workshop June 9, 2009.
Psychosocial Correlates of Youth Smoking in Mississippi Robert McMillen Nell Baldwin SSRC Social Science Research Center Mississippi State University.
Some thoughts about minimal dataset Róbert Urbán Smoking Cessation Center Budapest.
Nicotine Dependence: Comparing Menthol and Non-Menthol Cigarette Smokers Qiang Li, MS Andrew Hyland, PhD Gary Giovino, MS, PhD Joseph Bauer, PhD Michael.
Canadian Public Health Association 2008 Annual Conference Halifax, Nova Scotia, May 31 – June 4, 2008 Does Province of Residence Matter to the Health and.
Urban and Rural Disparities in Tobacco Use Ming Shan, BS; Zach Jump, MA; Elizabeth Lancet, MPH National Conference on Health Statistics August 8, 2012.
Laws/Policies ABSTRACT Problem: A challenge for tobacco control practitioners is getting smokers to quit using cessation methods. To increase the proportion.
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics Occupational exposure to.
Attempting to increase the use of smoking cessation medications Brendon Baker Ministry of Health.
TOBACCO RELATED MEDIA EXPOSURE AND INDICATORS OF SMOKING CESSATION Andrew Hyland, PhD Cheryl Higbee Melanie Wakefield, PhD Glen Szczypka, PhD Joseph Bauer,
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Grace Scott, MSc 1, Dr. Hosam Amoodi, MD 2, Dr. Damian Micomonaco, MD 2 1 Graduate Program in Health and Rehabilitation Sciences, _Western University 2.
Predictors of Child Health in Northern Ontario CPHA Annual Conference Halifax, Nova Scotia June 4, 2008 Darshaka Malaviarachchi, Epidemiologist, SDHU Derek.
Disability, Cigarette Smoking And Health-Related Quality Of Life: NYS Adult Tobacco Survey Harlan R. Juster, PhD Larry L. Steele, PhD Theresa M. Hinman,
E-Cigarette and Waterpipe Use Among Adolescents in Ontario Hayley A. Hamilton 1,2, Roberta Ferrence 2,3, Angela Boak 1, Robert Schwartz 1,2.3, Robert E.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
-Tobacco is the leading preventable cause of disease, disability, and death in the United States (NIDA, 2012). -About 1 in every 5 deaths in the U.S. result.
1 Key findings from the Smoking Toolkit Study University College London 19 January 2012 Robert West Jamie Brown Jenny Fidler.
1 University College London February 2014 Robert West Population impact of tobacco dependence treatment.
Smoking in England Robert West Jamie Brown University College London 1.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
1 Advising smokers on optimum pharmacotherapy for smoking cessation University College London April 2014 Robert West.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
The Research Data Centre Program October 14, 2015 DLI- EAC Donna Dosman.
Clare Meernik, MPH 1 ; Anna McCullough, MSW, MSPH, CTTS 1 ; Leah Ranney, PhD 1 ; Barbara Walsh 2 ; Adam O. Goldstein, MD, MPH 1 Predictors of Quit for.
Demographic Characteristics and Smoking Severity at entry into the SALOME Study Scott MacDonald 1, Eugenia Oviedo-Joekes 2,3, Kirsten Marchand 2,3, Daphne.
1 Effects on smoking cessation of a national strategy to maximise NRT usage: the UK experience Robert West University College London WCTOH July 2006 Washington.
1 Should behavioural support for smoking cessation address wider psychological problems? University College London October 2013 Robert West.
The Impact of Smoking Cessation Interventions by Multiple Health Professionals Lawrence An, MD 1 ; Steven Foldes, PhD 2 ; Nina Alesci, PhD 1 ; Patricia.
AN EXAMINATION OF THE PRACTICE OF TAILORING SMOKING CESSATION PHARMACOTHERAPY IN A TOBACCO TREATMENT PROGRAM WITHIN MENTAL HEALTH AND ADDICTIONS SETTINGS.
Smoking Cessation Medication
screening, brief intervention, and referral to treatment
FDA Authority to Regulate Tobacco Products Tobacco Control Act
Smoking and smoking cessation in the real world
Robert West University College London London March 2008
Behavioural and pharmacological approaches to treating smokers
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Cessation Guidelines for COPD
Nicotine replacement therapy
ABCs of Behavioral Support
Presentation transcript:

Neighborhood factors and quitting smoking in Ontario Presented by: Sarah Edwards *, Susan Bondy *, Russell Callaghan †,*, Robert Mann ‡,* * Dalla Lana School of Public Health, University of Toronto † University of Northern British Columbia ‡ Centre for Addiction and Mental Health, University of Toronto

1 in 5 Ontarians smoke

Objective To examine the association between cessation strategies used in attempts to quit and neighborhood factors. ?

Neighborhood Deprivation Smoking associated with: Neighborhood deprivation Neighborhoods with low socioeconomic status Use of cessation supports?

Urban-rural continuum Does use of cessation strategy differ by rural/urban location? Measure  urban-rural continuum from Statistics Canada

Ontario Tobacco Survey (OTS): Panel study of smokers 4500 Ontario smokers ( ) Representative telephone sample Followed-up every 6 months for up to 3 years Current analysis: Smoked at least 100 cigarettes (N = 4049) Quit attempts at reported at each follow-up (N = 5481 in 2080 individuals)

Methods – Data Sources OTS Postal Code

Outcome Quit attempt – reported at least one serious quit attempt or reported that they had stopped smoking for a period of time during follow-up (even if they do not identify it as an actual quit attempt) in the past 6 months – Assisted - reported using at least one of the following: Nicotine patches, gum, chewing pieces, lozenges or inhalers Zyban, bupropion, Wellbutrin, Champix or varenicline Group counselling or group support Specialized addiction counsellor – Unassisted– did not report using any of the above

Analyses Level of analysis  individual, repeated measures Neighbourhood measures  ecological level Analysis  needs to take into account impact of non-independence of data Mixed-effects models were used to examine relationship between neighborhood factors and quit outcomes Models were adjusted for clustering and potential individual-level confounders (age, sex, number of previous quit attempts, self-perceived addiction level)

The odds of quitting with assistance is 30% less for smokers living in rural versus urban areas in Ontario (adjusted p-value = 0.04).

The odds of quitting with assistance is 63% more for smokers living in areas with the least versus most ethnic concentration in Ontario (adjusted p-value = 0.004).

No Significant Differences Neighborhood level Deprivation Instability Dependency

Conclusions There is some evidence Ontario smokers living in rural areas are less likely to quit with assistance (may be a function of access) and there are some ethnic differences in terms of use or non-use of assisted quitting methods Other area level measures were not significantly associated with type of quit attempt

Limitations Self-report quit attempts Possible more than 1 quit attempt per 6 month period Individual-level variables not available for neighborhood-level variables  using ecological measures

Next Steps Examine additional social-environment factors: – Occupation (blue versus white collar) – Access to care (including interactions with rural/urban measure) – Social norms

Acknowledgements The OTS is an initiative of Ontario Tobacco Research Unit which receives funding from the Ontario Ministry of Health and Long-Term Care. My work is funded by the CIHR Training Grant in Population Intervention for Chronic Disease Prevention: A Pan- Canadian Program (Grant #: 53893).

Questions